跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ciprotam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ciprotam
Approved
STANDARD
Ciprotam
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
06fe91320acb164e
Company
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Type
Standard
Approval Details
Approval Id
06fe91320acb164e
Drug Approval Philippines Name
Ciprotam
Product Name
Ciprotam
Registration Number
DRP-11455-01
Brand Name
Ciprotam
Generic Name
Ciprofloxacin Hydrochloride
Dosage Form
Solution for Intravenous Injection
Dosage Strength
2 mg / mL (200 mg / 100 mL)
Manufacturer
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Importer
Medinova Pharmaceutical Inc
Distributor
Tamiga Pharmaceuticals Supply
Issuance Date
31 July 2023
Expiry Date
14 March 2027
Pharmacologic Category
Antibacterial (Fluoroquinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
06fe91320acb164e
Type
Standard
Back to Philippines FDA Approvals